In the context of leptin resistance—frequently observed in obesity and metabolic syndrome—leptin’s normal vasodilatory effects are blunted, while its mitogen-activated protein kinase (MAPK)-mediated vasoconstrictive and pro-inflammatory actions are preserved [19,38]. The gene discussed is WNK2; the disease is metabolic syndrome.